ID,MEDICATION,GENE(S),PRESCRIBING CONSIDERATIONS BASED ON myDNA TEST,INTERACTION
T37-066,Esomeprazole,CYP2C19,"Minor – result should be considered as may affect medicationresponse",INHIBITOR MODERATE:CYP2C19
T37-066,Ibuprofen,CYP2C9,"Minor – result should be considered as may affect medicationresponse",NA
T37-066,Ibuprofen (component of Ibuprofen+Methocar bamol Caplets),CYP2C9,"Minor – result should be considered as may affect medicationresponse",NA
T37-066,Naltrexone,OPRM1,Usual prescribing considerations apply,NA
T37-066,Venlafaxine,CYP2D6,Usual prescribing considerations apply,NA
T37-066,budesonide / eformoterol fumarate dihydrate (Symbicort Turbuhaler),NA,NO,NA
T37-066, salbutamol (Ventolin),NA,NO,NA
T37-066, bupropion,NA,NO,INHIBITOR STRONG: CYP2D6
T37-066, acetaminophen,NA,NO,NA
T37-066, methocarbamol (component of Ibuprofen+Methocarbamol Caplets),NA,NO,NA
